Time, the final frontier
Mol Oncol. 2025 Mar 24. doi: 10.1002/1878-0261.70025. Online ahead of print.
Published on March 24, 2025
ABSTRACT
Cancer’s notorious heterogeneity poses significant challenges, as each tumor comprises a unique ecosystem. While single-cell and spatial transcriptomics advancements have transformed our understanding of spatial diversity within tumors, the temporal dimension remains underexplored. Tumors are dynamic entities that continuously evolve and adapt, and relying solely on static snapshots obscures the intricate interplay between cancer cells and their microenvironment. Here, we advocate for integrating temporal dynamics into cancer research, emphasizing a fundamental shift from traditional endpoint experiments to data-driven, continuous approaches. This integration involves, for instance, the development of advanced live imaging techniques, innovative temporal omics methodologies, and novel computational tools.
PMID:40126098 | DOI:10.1002/1878-0261.70025
Latest Publications
- HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion
- Breast Milk Proteome: Changes in the Different Stages of Lactation and Impacts of Gestational Diabetes Mellitus and Body Mass Index
- Metabolome informs about the chemical exposome and links to brain health
- Designing Fluorescent Estrogen Mimetic 7-hydroxycoumarin Probe Substrates for Human Sulfotransferase Enzymes
- Cholesterol Ester Storage Disease in Two Field Spaniels With Lysosomal Acid Lipase Deficiency